Topic: Bats

Attorney Mike Yoder reviews 2015 NIH meeting minutes that discuss the potential for a SARS re-emergence through a "research accident in a laboratory." The documents mention using bat viruses as precursors and utilizing researchers in China with U.S. funding. Yoder argues these "hypothetical scenarios" were actually the battle plans for the eventual COVID-19 outbreak.

The discussion shifts to the scientific claim that vaccinating during a virus season with experimental shots creates pressure that causes dangerous mutations, a concept referred to as a "leaky vaccine." Jones suggests that bioweapon labs like EcoHealth Alliance may already have vaccines ready for variants that have not yet emerged in nature. He also notes reports of various viruses, including SARS, dengue, and polio, being monitored in wastewater and wild bird populations across the United States.

An "emergency fundraiser" was announced to counter what is described as a "sneak attack" in the state courts. Using the metaphor of a "1776 bat signal," the host compared the situation to Paul Revere's ride, calling for immediate financial support to keep the operation functional. The segment highlights that the donations will be used specifically for legal expenses associated with maintaining the broadcast's independence.

New reports indicate that a top FDA official admitted to a congressional committee that the government did not sufficiently inform the public about vaccine deaths. Additionally, Colorado State University is allegedly developing a "tier one" bat lab to research agents like Ebola. The host also claims that major blood companies are beginning to screen for vaccinated blood.

Bret Weinstein describes his "awakening" regarding COVID-19 origins after a Twitter follower pointed out the proximity of the Wuhan BSL-4 lab to the outbreak. He admits to initially supporting masks due to uncertainty about transmission methods but later changed his stance as evidence emerged. He emphasizes that the ability to improve one's model based on new evidence is the essence of science.

A bat biologist recounts an "awakening" regarding the origins of COVID-19 after a Twitter follower pointed out the proximity of the Wuhan biosafety lab to the initial outbreak. Initial support for masks and official narratives shifted as new data emerged, illustrating the scientific process of model improvement. The importance of admitting errors and adjusting to evidence is emphasized as a key trait for credible analysts.

Dr. Richard Bartlett returns to discuss the technical details of the Ervebo Ebola vaccine, noting its 31.7% shedding rate according to FDA inserts. He expresses concern over the construction of a new "Wuhan-style" bat research lab in Fort Collins, Colorado. Bartlett questions why Denver health officials are preparing for an Ebola outbreak now, suggesting they may have prior knowledge of potential risks.

Denver Health medical teams have received a live Ebola vaccine produced by Merck, despite no active outbreaks in the region. This coincides with the construction of a new bat research lab in Fort Collins, Colorado, which is reportedly funded to study high-consequence pathogens. FDA documents for the Ervebo vaccine confirm a significant shedding rate, raising concerns about secondary infections in the community.

DARPA documents cited by Tom Renz suggest that COVID-19 may have escaped from a lab as early as August 2019 in an "attenuated vaccine form." Renz discusses the development of aerosolized vaccines designed to be sprayed in bat caves, comparing this to the "shedding" phenomenon reported with mRNA vaccines. He argues that the distinction between the virus and the vaccine is increasingly blurred.

Dr. Redfield testifies that it was not "scientifically plausible" for a bat virus to become highly infectious to humans overnight without an intermediate host. He compares COVID-19 to SARS and MERS, which never mastered efficient human-to-human transmission. Redfield reiterates that he was sidelined from the February 2020 "Proximal Origin" paper discussions because he challenged the predetermined narrative.

Levy shares his thoughts on the documentary "Watch the Waters," which posits that COVID-19 may be related to snake venom rather than bats. He notes that Dr. Ardis, a proponent of this theory, was reportedly removed from a speaking tour. Levy argues that the medical freedom movement must be open to questioning all aspects of the pandemic's origins.

Harrison Smith announces a change in the day's hosting lineup, with Royce White and Dr. Jane Ruby set to fill in while Alex Jones deals with travel delays. The discussion returns to the State Department memo, noting that the Chinese Communist Party (CCP) knew of a "bat SARS-like coronavirus" in December 2019 but delayed public acknowledgment until the virus had already spread globally.

Leaked documents from the DRASTIC research team indicate that Wuhan scientists planned to release chimeric COVID spike proteins into bat populations using skin-penetrating nanoparticles. This research, conducted 18 months before the initial outbreak, aimed to inoculate bats but carried a high risk of human infection, leading DARPA to deny funding. The project involved creating human-specific cleavage sites to make the virus more infectious to people.

Karen Kingston, a pharmaceutical industry consultant, describes her investigation into FDA filings and vaccine patents which she claims read like bioweapon documentation. She asserts that research involving bat coronaviruses and chimeric super-viruses using HIV glycoproteins was used to create the injections. Kingston states she distributed a two-page report on these findings to media outlets and influencers in August 2021.

A 2019 video clip of Dr. Peter Daszak is played where he discusses the ease of manipulating coronaviruses in a lab by focusing on the spike protein. Daszak describes working with Ralph Baric at UNC to insert sequences into viral backbones to create predictive models for vaccines. The segment frames this as a confession of bioweapon development disguised as public health research.